fbpx

Vaccination funding should be consistent: Sim

31 January 2024

 

The Pharmaceutical Society of Australia (PSA) welcomes news that payments for pharmacist administration of COVID-19 vaccinations will be increased from tomorrow (1 February 2024) but urges similar increases across the National Immunisation Program Vaccinations in Pharmacy program.

 

The Pharmacy Programs Administrator (PPA) has confirmed that the new fee for COVID-19 Vaccine Administration Payments for all doses will be raised to $30.65. The Vaccination Incentive – Site Visit fee will not increase.

PSA National President A/Prof Fei Sim FPS said that increases should also apply to payments for NIPVIP vaccines.

“While I welcome increases in pharmacist remuneration for administering vital COVID-19 vaccines, it further highlights the growing inequality in funding for other vaccines delivered by pharmacists,” A/Prof Sim said.

“This change recognises the costs involved in delivering vaccination services, and it should be applied to all vaccines expected to be delivered by pharmacists. All vaccination services, regardless of whether under the COVID-19 Vaccination in Community Pharmacy Program or the National Immunisation Program Vaccinations in Pharmacy program, should be remunerated at the same rate.

This should include commitment to indexing of fees to keep pace with CPI, inclusion of rural loading, after hours incentives and incentives for reaching at risk and priority populations. The NIPVIP program should also support outreach services so pharmacists can support people wherever they live, including in aged care and disability facilities

“Adequate pharmacist remuneration is critical to ensuring that these essential services delivered by pharmacists can be delivered sustainably, which ultimately protects and maintains equitable access to vaccination services for all Australians.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Access to RSV vaccine critical to its efficacy

19 January 2024

 

Following the welcome approval of a new vaccine to protect older Australians against the highly infectious respiratory syncytial virus (RSV), the Pharmaceutical Society of Australia (PSA) is urging governments to ensure its accessibility for those most at risk.

This week the Therapeutic Goods Administration (TGA) approved AREXVY for Australians aged 60 and over, the first RSV vaccine approved in Australia.

PSA National President A/Prof Fei Sim FPS said that allowing pharmacists to administer the vaccine would significantly improve its uptake and in turn, reduce hospitalisations from severe infections.

“Having a vaccine on the market is not enough, we need to ensure that it’s as accessible as possible to those who need it most,” A/Prof Sim said.

“Pharmacist immunisers are limited by red-tape and regulation imposed by states and territories, preventing them from fulfilling their potential to administer all vaccines to all at-risk Australians.

“Millions of Australians attend pharmacies for their vaccinations, with more than 15 million COVID-19 and influenza vaccines administered by pharmacists over the last few years.

“By making vaccinations more accessible to vulnerable groups, we can limit the serious health complications RSV can cause and in turn reduce hospitalisations.

“Allowing pharmacists to practise to the top of their scope makes efficient use of health resources, benefitting the broader health system.

“I urge all state and territory governments to authorise pharmacists to provide the RSV vaccine, supporting access to preventive care and keeping older Australians healthy and well.

“This access should extend to all vaccines, for all eligible people, in all locations where pharmacists work.

“Reducing barriers to vaccination, reducing barriers to care, should always be our priority,” A/Prof Sim concluded.

AREXVY will soon be made available nationally, on private prescription.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

SA announces expanded vaccinations ahead of 1 Jan

22 December 2023

 

The South Australian Government have today announced expanded scope of pharmacist immunisers, allowing the administration of vaccines from 5 years of age as per both the South Australian and National Immunisation Program (NIP) Schedules This means from 1 January 2024, eligible patients can receive all vaccines on the NIP schedule in pharmacies free of charge.

The Pharmaceutical Society of Australia (PSA) SA/NT President Dr Manya Angley FPS welcomed the move.

“Improving access to  and removing cost barriers to receiving NIP vaccines in community pharmacies is a big win for South Australians,” Dr Angley said.

“As a state our focus should be on removing barriers to vaccination, cutting the red tape that prevents qualified pharmacist immunisers from delivering more vaccines to more people while easing pressure on GPs.

“For pharmacists this is not only an opportunity to provide more vaccination services but also to drive public health messaging, encouraging vaccine uptake particularly in vulnerable cohorts.

“Our health system needs all immunisers to play a role in delivering vaccines wherever there is a patient need.

 

“I am proud to see years of PSA’s advocacy has led to real outcomes not only for the pharmacists who will be able to play a greater role in delivering vaccines, but for our communities who will be able to access eligible vaccines closer to home, at their convenience.

“We look forward to continuing to work with SA Health and the SA Government to ensure that all South Australians have access to quality health care, no matter where they live,” Dr Angley concluded.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

NT Pharmacists to administer more vaccines to more Territorians

19 December 2023

 

The Pharmaceutical Society of Australia (PSA) welcomes the Northern Territory Government’s move to cut unnecessary red tape and allow qualified pharmacist-immunisers to administer a wider range of vaccines from early next year.

From 1 January 2024, pharmacist-immunisers will be authorised to administer all vaccines listed on the National Immunisation Program (NIP) Schedule, including as private vaccines to those who are not eligible for NIP funding, for consumers aged five years and older.

The update also authorises pharmacists to administer vaccines outside of community pharmacy settings, opening the door for pharmacist-led vaccination outreach clinics across the Territory.

PSA Northern Territory and South Australia President Dr Manya Angley FPS said that these changes send the right message to the community.

“Maintaining immunisation is a lifelong commitment and pharmacists are accessible and trusted health practitioners in communities throughout the Northern Territory,” Dr Angley said.

“There should be no wrong door when a patient is seeking a vaccine, whether from their local GP or pharmacist.

“Allowing pharmacists to administer vaccines in a range of settings also unlocks the full potential of our immunisation workforce, allowing outreach clinics to offer targeted health promotions.

“I am proud to see years of PSA’s advocacy has led to real outcomes not only for the pharmacists who will be able to play a greater role in delivering vaccines, but for our communities who will be able to access eligible vaccines closer to home, at their convenience.

“We look forward to continuing to work with NT Health and the NT Government to ensure that all Territorians have access to quality health care, no matter where they live,” Dr Angley concluded.

Ahead of the NIP Vaccination in Pharmacies expansion on 1 January 2024, PSA has released a comprehensive and updated immunisation course for pharmacists with renewed clinical content, interactive videos and revised layout.

The updated PSA immunisation training program is available to all pharmacists here.

PSA members can now enrol in immunisation refresher course for free here.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

National access to vaccines must be a priority

30 November 2023

 

The Pharmaceutical Society of Australia (PSA) is again calling for vaccines to be made accessible to more Australians by fully utilising pharmacists as part of the immunisation workforce, following a new report from Australian think tank Grattan Institute.

The Grattan Institute report A fair shot: How to close the vaccination gap specifically recommends action on a National Vaccines Partnership Agreement and harmonisation of the state-based regulations that determine pharmacists’ authority to deliver certain vaccines.

The report also calls for new funding for Primary Health Networks (PHNs) to support general practice, pharmacists, and aged care providers to promote vaccination in mainstream primary care.

PSA National President Dr Fei Sim FPS welcomes the Grattan Institute’s recommendations, which echo PSA’s calls for nationally consistent vaccination authorities.

“The Grattan Institute’s report is a stark look at how far we still have to go to make vaccination equitable for all Australians,” Dr Sim says.

“We know that there is no one-size-fits-all approach to improving vaccine uptake, with the report rightly highlighting the need for a tailored approach to ensuring vulnerable cohorts don’t fall through the cracks.

“The Federal Government’s move to open up National Immunisation Program funding for pharmacist-administered vaccines is a welcome first step, but there is more work to be done to allow pharmacists to deliver all vaccines to patients of all ages.

“At the moment, every jurisdiction in Australia has different regulations around which vaccinations can be administered by pharmacists.

“A nationally consistent schedule of pharmacist-administered vaccines is key to achieve equitable access to government-funded vaccines by all Australians.

“Pharmacists can and should be utilised as trusted health care professionals, working hand in glove with the rest of the primary care team to break down the barriers to vaccination, from improving equity and access, to amplifying public health messages.

“Our health system needs all immunisers to play a role in delivering vaccines wherever there is a patient need, whether a GP, nurse practitioner or pharmacist,” Dr Sim concluded.

The Grattan Institute’s A fair shot: How to close the vaccination gap report is available here.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Vaccine certainty protects Queenslanders

2 November 2023

 

Queensland Health Minister Shannon Fentiman MP has today announced that the Queensland Government will invest $40 million to ensure every Queenslander will have access free influenza vaccinations in 2024.

Under the National Immunisation Program (NIP) children aged six months to five years, pregnant women, people aged 65 and over, First Nations people and those with certain medical conditions can access no-cost vaccinations, while Australians outside of these groups pay a private fee to receive an influenza vaccination.

PSA Queensland President Shane MacDonald MPS welcomed the announcement.

“Removing cost barriers and giving Queenslanders greater access to vaccines is a great first step to improving vaccine uptake,” Mr MacDonald said.

“Queensland still falls behind national influenza coverage in almost every age group, an ongoing challenge that needs action from the whole health system, including government and all healthcare professionals.

“This is a common-sense approach to improving vaccination coverage.

“Funding certainty ahead of the 2024 flu season will mean that pharmacists can adequately prepare and meet increased demand.

“Knowing that every patient will have access to a vaccination at no cost, pharmacists can start having conversations now to encourage our patients to get their vaccine before the start of flu season.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Queensland leading nation on pharmacist vaccination scope

30 October 2023

 

Queensland is continuing to lead the nation on vaccination policy, with Health Minister the Hon. Shannon Fentiman MP today announcing expanded vaccination scope for Queensland pharmacists from 30 October 2023.

The new Extended Practice Authority (EPA) will allow pharmacists to vaccinate Queenslanders aged 2 years and older and will also authorise pharmacists to deliver vaccinations in more settings, including general practices, Aboriginal or Torres Strait Islander health services, and aged care facilities.

The new EPA will also enable pharmacists to deliver a wider range of vaccines including:

  • Hepatitis B
  • Varicella (chickenpox)
  • Meningococcal B
  • Human papillomavirus (HPV)
  • Typhoid fever
  • Zoster (herpes zoster), and
  • Japanese encephalitis.

Pharmaceutical Society of Australia (PSA) Queensland President Shane MacDonald MPS welcomed the move and the Queensland Government’s ongoing commitment to improving access to health services.

“Allowing more people to be vaccinated by their local pharmacist is a vital step in not only protecting individual Queenslanders but the entire community,” Mr MacDonald said.

“PSA has strongly advocated for pharmacists across all health settings to be able to deliver more vaccines to patients of all ages. This is a great step toward pharmacists practising to our full potential to support the health of our communities.

“On behalf of pharmacists I thank Minister Fentiman for her commitment to improving health care and ensuring that vaccinations are accessible to all Queenslanders.

“PSA also supports the authorisation of pharmacists to administer prescribed medicines in the new EPA. This is a common sense, consumer centric approach which will support patients experiencing issues with administering their own medications or accessing a health professional to administer.

“I look forward to continuing to work with the Minister and the Queensland Government to promote these new services to the community and to continue to ensure that pharmacists can practise to our top of scope and best support the health of our state,” Mr MacDonald concluded.

PSA National President Dr Fei Sim FPS said it was vital for regulations around vaccination to be consistent across all states and territories.

“At the moment, every jurisdiction in Australia has different regulations around which vaccinations can be administered by pharmacists.

“Australians should be able to access the same level of health care regardless of where they live. A nationally consistent schedule of pharmacist-administered vaccinations is key to achieve equitable access to government-funded vaccines by all Australians.

“Our health system needs all trained immunisers to play a role in delivering vaccines. We need qualified pharmacists to be able to administer vaccines wherever there is a patient need.

“I urge all states and territories to follow Queensland’s lead and allow all pharmacist immunisers, regardless of practice setting, to administer more vaccines to more Australians.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists applaud NSW red-tape cut and vaccine expansion

27 October 2023

 

The Pharmaceutical Society of Australia (PSA) welcomes the New South Wales Government’s move to expand vaccination access, with updates to the NSW Pharmacist Vaccination Standards expanding access to National Immunisation Program (NIP) vaccines, lowering minimum age requirements for Shingrix vaccines and removing written consent requirement for COVID-19 vaccines.

 

PSA New South Wales President Luke Kelly FPS said the changes cut unnecessary red tape, making vaccines more accessible across the state.

 

“As a state our focus should be on removing barriers to vaccination, cutting the red tape that prevents qualified pharmacist immunisers from delivering more vaccines to more people,” Mr Kelly said.

 

“I am proud to see years of PSA’s advocacy led to real outcomes not only for the pharmacists who will be able to play a greater role in delivering vaccines, but for our communities who will be able to access eligible vaccines closer to home.

 

“I thank the NSW Government for moving to expand NIP access for our most vulnerable populations and look forward to continuing to work alongside them to improve vaccine uptake across New South Wales.”

 

Summary of vaccination changes in NSW:

  • Lowering of the age range that pharmacist immunisers can administer Shingrix vaccine to 18 years and over (was previously 50 years and over) to align with the eligibility for Shingrix vaccine under the NIP.
  • Inclusion of monovalent meningococcal C vaccine for people aged 5 years and over to ensure pharmacist immunisers can provide a full range of meningococcal vaccines to eligible cohorts.
  • Removal of reference to COVID-19 vaccine following the recent inclusion of COVID-19 vaccine in the Australian Immunisation Handbook to be consistent with the approach for all other vaccines that pharmacist immunisers are authorised to immunise.
  • Removal of the COVID-19 vaccine written consent requirements to be consistent with consent requirements for all other vaccines i.e., that informed consent must be obtained, and documented evidence of verbal consent must be made.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Better access to medicines a huge win for NSW patients

13 November 2022

 

The Pharmaceutical Society of Australia (PSA) welcomes today’s announcement from New South Wales Premier Dominic Perrottet, improving access to medicines and vaccines by expanding the scope of practice for NSW pharmacists.

 

The NSW Government has committed to a 12-month trial allowing pharmacists to prescribe medication for urinary tract infections (UTIs) similar to the program already trialled in Queensland, as well as a state-wide trial of pharmacist prescribing for oral contraceptives, and medication for ear infections and minor skin ailments.

 

Pharmacists will also be able to administer more vaccinations from Monday 14 November, including Hepatitis A, Hepatitis B, Japanese Encephalitis Virus (JEV), Poliomyelitis, Typhoid, and Zoster vaccines.

 

PSA NSW President Chelsea Felkai said the move will improve access to medicines and vaccination for residents across NSW, helping to address current GP shortages.

 

“Giving patients across NSW greater access to vaccinations, contraception and medicines for minor ailments through local pharmacies will significantly improve access to healthcare, especially in regional and rural parts of the state,” Ms Felkai said.

 

“Trained Queensland pharmacists have been successfully prescribing for uncomplicated UTIs since 2020, giving patients timely access to medicines in an environment where it could otherwise take up to six weeks to get a GP appointment.

 

“Pharmacists have the skills and expertise to renew patient prescriptions for ongoing health concerns, especially where their chronic condition is stable, removing barriers to medicine access.

 

“As the most accessible healthcare professional, pharmacists should be able to offer patients renewals of their ongoing medications. Allowing pharmacists to renew prescriptions for oral contraceptives is the first step in giving patients greater access to medicines for stable but chronic conditions that have already been diagnosed.”

 

Ms Felkai said the community has demonstrated their confidence in pharmacist-administered vaccines throughout the pandemic, with pharmacists now firmly entrenched as part of Australia’s immuniser workforce:

 

“We share the concerns NSW Health has on the potential for Japanese Encephalitis outbreaks in regional NSW this summer. We are proud that pharmacists will be able to play their part in helping at-risk people protect themselves against this disease.

 

“While the world has re-opened to travel, the health system remains under significant pressure. Providing patients with more options to access travel vaccinations just makes sense.

 

“Pharmacists are trained and experienced immunisers. In community pharmacies alone, over 9 million COVID-19 vaccines have been administered, and that doesn’t to count the doses pharmacists have administered in hubs, general practices or aged care facilities.

 

“This is an important vote of confidence in pharmacists across NSW, in our skills and expertise as part of the primary healthcare team. We thank the NSW Government for their support and look forward to working with the NSW Government to implement these measures.

PSA National President, Dr Fei Sim, also commended the NSW Government on this announcement, and called on other jurisdictions to follow suit.

 

“PSA has been calling on governments around Australia to allow pharmacists to play a greater role in community health. It’s great to see NSW leading the way in improving patient access to medicines. Pharmacists have the skills and medicine expertise to renew prescriptions for stable, chronic conditions. With ongoing GP shortages across the country, it is time for other jurisdictions to follow NSW’s lead.

 

 

Media contact:   Georgia Clarke   M: 0410 505 315     E: georgia.clarke@psa.org.au